Showing 4481-4490 of 10632 results for "".
Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
https://reachmd.com/programs/spotlight-subcutaneous-cancer-immunotherapies/nanrilkefusp-alfa-a-promising-subcutaneous-il-15r-superagonist/32991/Read about the mechanisms, safety, and efficacy of nanrilkefusp alfa, an IL-15 receptor βγ superagonist designed to stimulate NK and CD8+ T cells.Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
https://reachmd.com/programs/neurofrontiers/beyond-amyloid-and-tau-a-multimarker-approach-to-alzheimers-detection/29095/Blood tests may be able to detect early signs of Alzheimer’s by measuring markers related to brain inflammation, blood vessel health, and nerve connections.The Power of Patient Advocacy in Daily Clinical Practice
https://reachmd.com/programs/project-oncology/the-power-of-patient-advocacy-in-daily-clinical-practice/24501/How can we incorporate patient advocacy into daily practice? Tune in.Shedding Light on Spaceflight-Associated Neuro-Ocular Syndrome
https://reachmd.com/programs/clinicians-roundtable/shedding-light-on-spaceflight-associated-neuro-ocular-syndrome/10842/There’s a troubling ailment affecting astronauts’ brain and eyes, so strap in as we sit down with the organization at the heart of this issue: NASA.Unlocking Early Detection of IgA Nephropathy: The Critical Role of Timely Diagnosis
https://reachmd.com/programs/frontlines-iga-nephropathy/unlocking-early-detection-of-iga-nephropathy-the-critical-role-of-timely-diagnosis/26945/Here’s how early identification of IgA nephropathy can improve patient outcomes.Identifying Central and Branch Retinal Vein Occlusion
https://reachmd.com/programs/eye-on-ocular-health/identifying-central-and-branch-retinal-vein-occlusion/54486/When a patient presents with sudden, painless vision loss, recognizing the subtle but critical differences between retinal conditions can make all the difference in outcomes. Tune in to hear Dr. Jessica Randolph break down the hallmark signs of central and branch retinal vein occlusion and share praRise in Early-Onset Colon Cancer Being Studied Through Single-Cell Sequencing
https://reachmd.com/programs/medical-industry-feature/rise-in-early-onset-colon-cancer-being-studied-through-single-cell-sequencing/29922/What’s behind the rise in colon cancer in younger patients? Listen to a breakdown of key trends, possible causes, and ongoing research to find answers.Managing Eye-Related Adverse Events Caused by Cancer Treatments
https://reachmd.com/programs/medical-industry-feature/managing-eye-related-adverse-events-caused-by-cancer-treatments/36171/Some cancer medicines may cause problems with the eyes or with vision.1-3 Most of these eye-related adverse events can be mild, brief, intermittent, and reversible,1,3-6 but others may be long-lasting and could involve permanent vision loss or structural changes of the eye.1,2,7 As a result, it’s imCracking the Migraine Code: How AI May Transform Diagnosis and Treatment
https://reachmd.com/programs/frontlines-migraine/migraine-ai-diagnosis-treatment/48938/Migraine is a highly prevalent and complex neurologic disorder, but many patients face delays in diagnosis, limited access to specialists, and suboptimal treatment pathways. However, emerging artificial intelligence (AI) tools offer new opportunities to improve access to care and personalize therapyA Sneak Peek at Digestive Disease Week 2024
https://reachmd.com/programs/gi-insights/a-sneak-peek-at-digestive-disease-week-2024/24327/Here are some highlights of what’s to come at Digestive Disease Week 2024.